» Subscribe Today!
More of what you want to know.
The Daily News
X

Forgot your password?
Skip Navigation LinksHome >
VOL. 127 | NO. 90 | Tuesday, May 08, 2012

Tennessee Will Get $1.95 Million From Drug Agreement

AP

Print | Front Page | Email this story | Comments ()

NASHVILLE (AP) – Tennessee will receive $1.95 million coming from a multistate settlement between a giant pharmaceutical company accused of deceptively marketing the anti-seizure drug Depakote.

The state's cut was part of a $100 million agreement between 45 states and the District of Columbia and Abbott Laboratories. The agreement is the largest consumer protection-based pharmaceutical settlement ever reached.

The states accused the pharmaceutical company of engaging in deceptive marketing practices when it marketed Depakote for off-label uses. Depakote has been approved for the treatment of seizures, migraine headaches and mania associated with bipolar disorder. The states said the company marketed the drug to treat medical issues where the drug has not been approved, such as schizophrenia, agitated dementia and autism.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sign-Up For Our Free Email Edition
Get the news first with our daily email


 
Blog Get more from The Daily News
Blog News, Training & Events
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 70 125 13,455
MORTGAGES 119 192 17,541
FORECLOSURE NOTICES 19 51 3,442
BUILDING PERMITS 146 769 31,699
BANKRUPTCIES 62 128 12,823
BUSINESS LICENSES 40 51 4,648
UTILITY CONNECTIONS 80 233 19,690
MARRIAGE LICENSES 25 69 4,129

Weekly Edition

Issues | About

The Memphis News: Business, politics, and the public interest.